secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001104659-22-110305
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Q2 revenue $269.5M (+86% YoY); CFO resigns, interim named; FY22 revenue guidance raised to $1.025-1.075B
--------------------------------------------------------------------------------

- CFO Eric Atkins resigns effective Nov 1, 2022; Erin Darakjian appointed interim CFO (VP & CAO since Aug 2022).
- Q2 revenue $269.5M (+86% YoY); net loss $903.1M includes $851.5M goodwill impairment.
- Adjusted EBITDA loss PMPM improved to $94 from $119 in Q2 2021.
- Raising full-year 2022 revenue guidance to $1.025-1.075B (from $637M in 2021).
- At-risk Medicare Advantage members exceed 100k as of June 30; expanded Humana partnership in Nevada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/0001104659-22-110305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/tm2228527d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-110305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer